Method for providing a wrap-around shield for a magnetic recording transducer
    1.
    发明授权
    Method for providing a wrap-around shield for a magnetic recording transducer 有权
    提供用于磁记录传感器的环绕屏蔽的方法

    公开(公告)号:US08322023B1

    公开(公告)日:2012-12-04

    申请号:US12615544

    申请日:2009-11-10

    Abstract: A method for fabricating a magnetic transducer is described. The magnetic transducer includes a pole having a pole tip and a flared region. The method Includes providing a first mask layer on the pole and providing a second mask layer on the first mask layer. The first mask layer is soluble in a predetermined solution and has a first thickness. The second mask layer has a second thickness greater than the first thickness. The method also includes forming a mask from the first mask layer and the second mask layer. The step of forming the mask layer includes using the predetermined solution. The mask has a pattern that exposes a portion of the pole tip and covers a portion of the flared region. The method also includes providing a wrap-around shield on at least the pole tip.

    Abstract translation: 描述了用于制造磁换能器的方法。 磁换能器包括具有极尖和扩口区域的极。 该方法包括在极点上提供第一掩模层,并在第一掩模层上提供第二掩模层。 第一掩模层可溶于预定溶液并具有第一厚度。 第二掩模层具有大于第一厚度的第二厚度。 该方法还包括从第一掩模层和第二掩模层形成掩模。 形成掩模层的步骤包括使用预定的溶液。 掩模具有暴露极尖的一部分并覆盖扩张区域的一部分的图案。 该方法还包括在至少极尖上提供环绕屏蔽。

    Method and system for providing optical proximity correction for structures such as a PMR nose
    3.
    发明授权
    Method and system for providing optical proximity correction for structures such as a PMR nose 有权
    用于为诸如PMR鼻子的结构提供光学邻近校正的方法和系统

    公开(公告)号:US07910267B1

    公开(公告)日:2011-03-22

    申请号:US12333699

    申请日:2008-12-12

    CPC classification number: G03F1/36

    Abstract: An optical mask for providing a pattern for portion of an electronic device, such as a magnetic recording transducer, is disclosed. The optical mask includes a device feature and at least one detached correction feature. The device feature includes a corner corresponding to a device corner of the pattern. The device corner has an angle of greater than zero degrees and less than one hundred eighty degrees. The at least one detached correction feature resides in proximity to but is physically separated from the corner. Each of the at least one detached correction feature is sub-resolution.

    Abstract translation: 公开了一种用于为诸如磁记录换能器的电子设备的一部分提供图案的光掩模。 光学掩模包括设备特征和至少一个分离的校正特征。 设备特征包括与图案的设备角对应的角。 设备角具有大于零度且小于百八十度的角度。 至少一个分离的校正特征位于附近,但是与角部物理分离。 至少一个分离的校正特征中的每一个都是子分辨率。

    Process for manufacturing a perpendicular magnetic recording writer pole with nonmagnetic bevel
    4.
    发明授权
    Process for manufacturing a perpendicular magnetic recording writer pole with nonmagnetic bevel 失效
    制造具有非磁性斜面的垂直磁记录刻录机的方法

    公开(公告)号:US08628672B1

    公开(公告)日:2014-01-14

    申请号:US13535091

    申请日:2012-06-27

    CPC classification number: G11B5/315 G11B5/1278 G11B5/3116 G11B5/3163

    Abstract: A method for fabricating a magnetic recording transducer having a magnetic writer pole with a short effective throat height is provided. In an embodiment, a writer structure comprising a magnetic writer pole having a trailing bevel and a nonmagnetic stack on the top surface of the writer pole is provided. A dielectric write gap layer comprising alumina is deposited over the trailing bevel section and the nonmagnetic stack; and at least one etch stop layer is deposited over the dielectric write gap layer. A layer of nonmagnetic fill material is deposited over the etch stop layer and to form a nonmagnetic bevel by performing a dry etch process. The etch stop layer(s) are removed from the short throat section; and a trailing shield is deposited over the short throat section, nonmagnetic bevel, and nonmagnetic stack top surface.

    Abstract translation: 提供一种制造具有具有短的有效喉部高度的磁性写入极的磁记录换能器的方法。 在一个实施例中,提供了一种写入器结构,其包括在写入器极的顶表面上具有后斜面和非磁性堆叠的磁性写入极。 包含氧化铝的电介质写入间隙层沉积在后斜面部分和非磁性层上; 并且至少一个蚀刻停止层沉积在电介质写间隙层上。 一层非磁性填充材料沉积在蚀刻停止层上并通过执行干法蚀刻工艺形成非磁性斜面。 蚀刻停止层从短喉部分移除; 并且尾部屏蔽层沉积在短喉部分,非磁性斜面和非磁性堆叠顶表面上。

    Wire configuration and method of making for an implantable medical apparatus
    6.
    发明授权
    Wire configuration and method of making for an implantable medical apparatus 有权
    电线配置和可植入医疗器械的制造方法

    公开(公告)号:US08639352B2

    公开(公告)日:2014-01-28

    申请号:US12419082

    申请日:2009-04-06

    Abstract: A filar includes an inner conductive core that is formed of a low-resistivity material such as silver having a resistivity of less than 20 μΩ per centimeter. A conductive coil is provided around the core to form a filar. This coil is formed of a biocompatible alloy or super alloy having an ultimate tensile strength (UTS) of between 150 kilo pounds per square inch (ksi) and 280 ksi at room temperature. Examples of such alloys include CoCrMo, CoFeCrMo, and CoFeNiCrMo. In one specific embodiment, the alloy is MP35N (CoNiCrMo), which may be low-titanium (“low-ti”) MP35N. One or more such filars may be included within a wire. This wire may be carried by an implantable medical apparatus such as a lead, lead extension, or catheter. The wire may electrically couple elements such as connector electrodes to conducting electrodes or sensors.

    Abstract translation: 丝状物包括由诸如银的低电阻率材料形成的内导电芯,其电阻率小于每平方厘米20微米。 在芯周围设置导电线圈以形成丝状体。 该线圈由在室温下具有150千磅/平方英寸(ksi)和280ksi之间的极限拉伸强度(UTS)的生物相容性合金或超级合金形成。 这种合金的实例包括CoCrMo,CoFeCrMo和CoFeNiCrMo。 在一个具体实施方案中,合金是MP35N(CoNiCrMo),其可以是低钛(“低钛”)MP35N。 一根或多根这样的丝状物可以包括在线内。 该线可以由诸如铅,引线延伸或导管的可植入医疗设备携带。 导线可以将诸如连接器电极的元件电耦合到导电电极或传感器。

    Recombinant human interferon-like proteins
    7.
    发明授权
    Recombinant human interferon-like proteins 有权
    重组人干扰素样蛋白

    公开(公告)号:US08425895B2

    公开(公告)日:2013-04-23

    申请号:US12665682

    申请日:2007-06-22

    CPC classification number: C07K14/56 A61K38/00 C07K14/555

    Abstract: This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID NO: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.

    Abstract translation: 本申请涉及重组人类干扰素样蛋白。 在一个实施方案中,与天然存在的人干扰素α2b(HuIFN-α2b)相比,描述了通过基因改组技术产生的重组蛋白质具有增强的抗病毒和抗增殖活性。 本发明包括编码蛋白质的多核苷酸和包含多核苷酸的重组载体和宿主细胞。 优选地,多核苷酸选自各自具有与SEQ ID:No.1至少93%相同的序列的多核苷酸,并且所述蛋白质选自蛋白质组,其各自具有与SEQ ID NO:至少85%相同的氨基酸序列 包含蛋白质的蛋白质和组合物可用于治疗对干扰素治疗(例如病毒性疾病和癌症)有反应的病症。

    Serializer with odd gearing ratio
    8.
    发明授权
    Serializer with odd gearing ratio 有权
    具有奇数传动比的串行器

    公开(公告)号:US08274412B1

    公开(公告)日:2012-09-25

    申请号:US12987393

    申请日:2011-01-10

    CPC classification number: H03M9/00

    Abstract: In certain embodiments of the invention, a serializer has (a) an initial, transfer stage that transfers incoming parallel data from a relatively slow timing domain to a relatively fast timing domain and (b) a final, serializing stage that converts the parallel data into serialized data. Between the transfer stage and the serializing stage is an update stage that (i) buffers data between the initial and final stages and (ii) can be used to toggle the serializer between an N−1 operating mode (that serializes (N−1) bits of parallel data) and an N+1 operating mode (that serializes (N+1) bits of parallel data) to achieve a net N:1 gearing ratio where N is an odd integer. The serializer can be configurable to support other gearing ratios as well.

    Abstract translation: 在本发明的某些实施例中,串行器具有(a)初始传送级,其将输入的并行数据从相对较慢的定时域传送到相对较快的定时域,以及(b)将并行数据转换成 序列化数据。 在转移阶段和序列化阶段之间是更新阶段,(i)缓冲初始阶段和最后阶段之间的数据,(ii)可用于在N-1操作模式(序列化(N-1) 并行数据的位)和N + 1工作模式(串行化并行数据的(N + 1)位),以实现净N:1的传动比,其中N是奇整数。 串行器可以配置为支持其他传动比。

    Entity-based business intelligence
    9.
    发明授权
    Entity-based business intelligence 有权
    基于实体的商业智能

    公开(公告)号:US07792856B2

    公开(公告)日:2010-09-07

    申请号:US11771668

    申请日:2007-06-29

    CPC classification number: G06F17/30592 G06F17/30489

    Abstract: A method is disclosed for conducting a query to transform data in a pre-existing database, the method comprising: collecting database information from the pre-existing database, the database information including inconsistent dimensional tables and fact tables; running an entity discovery process on the inconsistent dimensional tables and the fact tables to produce entity mapping tables; using the entity mapping tables to resolve the inconsistent dimensional tables into resolved dimensional tables; and running the query on a resolved database to obtain a query result, the resolved database including the resolved dimensional table.

    Abstract translation: 公开了一种用于进行在预先存在的数据库中转换数据的查询的方法,所述方法包括:从预先存在的数据库收集数据库信息,所述数据库信息包括不一致的维度表和事实表; 对不一致的维度表和事实表运行实体发现过程以生成实体映射表; 使用实体映射表将不一致的维度表解析为已解析的维度表; 并在解析的数据库上运行查询以获取查询结果,解析的数据库包括已解析的维度表。

    Recombinant human interferon-like proteins
    10.
    发明授权
    Recombinant human interferon-like proteins 有权
    重组人干扰素样蛋白

    公开(公告)号:US07625555B2

    公开(公告)日:2009-12-01

    申请号:US11764786

    申请日:2007-06-18

    CPC classification number: C07K14/56 A61K38/00 C07K14/555

    Abstract: This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.

    Abstract translation: 本申请涉及重组人类干扰素样蛋白。 在一个实施方案中,与天然存在的人干扰素α2b(HuIFN-α2b)相比,描述了通过基因改组技术产生的重组蛋白质具有增强的抗病毒和抗增殖活性。 本发明包括编码蛋白质的多核苷酸和包含多核苷酸的重组载体和宿主细胞。 优选地,多核苷酸选自各自具有与SEQ ID:No.1至少93%相同的序列的多核苷酸,并且所述蛋白质选自蛋白质组,其各自具有与SEQ ID NO:至少85%相同的氨基酸序列 否:2.包含蛋白质的蛋白质和组合物可用于治疗对干扰素治疗(例如病毒性疾病和癌症)有反应的病症。

Patent Agency Ranking